Nambu Y, Iannettoni M D, Orringer M B, Beer D G
Department of Internal Medicine, Kanazawa Medical University, Ishikawa, Japan.
Mol Carcinog. 1998 Dec;23(4):234-42.
The identification of markers that distinguish primary pulmonary adenocarcinomas from pulmonary adenocarcinomas secondary to the digestive tract would be clinically important. Villin, a specific marker in digestive-tract malignancies, was evaluated in 57 pulmonary adenocarcinomas, six samples of proximal bronchial tissue, and five metastatic pulmonary adenocarcinomas (three colon and two esophageal adenocarcinomas) by using immunohistochemical and molecular analyses. Villin was expressed in 31.6% (18 of 57) of the pulmonary adenocarcinomas and showed either a diffuse cytoplasmic pattern (10.5%) or a primary cytoplasmic pattern with minor brush-border staining (21.1%). However, none of those samples demonstrated the primary brush-border staining pattern that was characteristic of all five of the metastatic digestive-tract adenocarcinomas. There was a significant difference in the positive brush-border staining pattern between the primary and metastatic pulmonary adenocarcinomas (P < 0.002). Villin protein was expressed in bronchial epithelial cells, and villin mRNA was detected by reverse transcription-polymerase chain reaction. Northern analysis demonstrated 3.5- and 2.7-kb villin mRNAs in villin protein-positive tumors, but villin mRNA was not detected in non-tumorous lung tissue, indicating the transcriptional upregulation of villin in lung tumors. An additional smaller-sized mRNA (1.8 kb) was observed in six of 10 pulmonary adenocarcinomas and in the bronchoalveolar carcinoma cell line A549. Two small villin mRNAs were cloned from the cell line A549 and were found to represent an alternatively spliced (exon 8-exon 14) 1.85-kb mRNA and a 1.8-kb mRNA that was missing a portion of the 5' region (exon 1-exon 9) of the native villin mRNA. These studies demonstrated that the pattern of villin expression and the presence of altered villin mRNAs may be useful markers for pulmonary adenocarcinomas as well as provide support for the potential origin of villin-expressing tumors from bronchial epithelial cells.
鉴别原发性肺腺癌与继发于消化道的肺腺癌的标志物具有重要临床意义。采用免疫组化和分子分析方法,对57例肺腺癌、6例近端支气管组织样本以及5例转移性肺腺癌(3例结肠腺癌和2例食管腺癌)进行了消化道恶性肿瘤特异性标志物绒毛蛋白(villin)的评估。57例肺腺癌中31.6%(18/57)表达villin,表现为弥漫性胞质模式(10.5%)或主要为胞质模式伴少量刷状缘染色(21.1%)。然而,这些样本均未显示出所有5例转移性消化道腺癌所特有的原发性刷状缘染色模式。原发性和转移性肺腺癌的阳性刷状缘染色模式存在显著差异(P < 0.002)。villin蛋白在支气管上皮细胞中表达,通过逆转录聚合酶链反应检测到villin mRNA。Northern分析显示,villin蛋白阳性肿瘤中存在3.5 kb和2.7 kb的villin mRNA,但在非肿瘤性肺组织中未检测到villin mRNA,表明肺肿瘤中villin转录上调。在10例肺腺癌中的6例以及支气管肺泡癌细胞系A549中观察到另外一种较小尺寸的mRNA(1.8 kb)。从细胞系A549中克隆出两种小villin mRNA,发现它们分别代表一种选择性剪接(外显子8 - 外显子14)的1.85 kb mRNA和一种缺失天然villin mRNA 5'区域(外显子1 - 外显子9)部分的1.8 kb mRNA。这些研究表明,villin表达模式以及改变的villin mRNA的存在可能是肺腺癌的有用标志物,同时也支持了表达villin的肿瘤可能起源于支气管上皮细胞的观点。